Physician profile
Adam Hare
NPI 1568881753
$9,476.97
in general payments reported to CMS, 2019-2025
18 companies · $2,453 in 2025
The $2,453 reported for 2025 was more than what 86% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2021: $3,510 · 2022: $688 · 2023: $931 · 2024: $1,425 · 2025: $2,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,824 · Travel and Lodging: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,823.51 |
| Travel and Lodging | $985.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,172.04 | 2021 | |
| Medtronic, INC. | $1,522.38 | 2021-2025 | Interstim, Ligasure |
| Coloplast Corp | $1,323.29 | 2021-2025 | Altis |
| Applied Medical Resources Corporation | $1,124.88 | 2024-2025 | |
| Boston Scientific Corporation | $564.33 | 2019-2025 | General - Therapies, Upsylon, Advantage System |
| Caldera Medical, INC | $354.68 | 2023-2025 | Desara |
| Axonics, INC. | $310.99 | 2021-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $288.20 | 2019-2024 | Veozah |
| Teleflex LLC | $189.19 | 2024-2025 | Solesta, Quikclot |
| Hologic Sales and Service, LLC | $163.82 | 2023-2024 | Acessa Provu System, Aptima |
| Abbvie INC. | $141.57 | 2022-2023 | |
| Palette Life Sciences, INC. | $135.42 | 2022 | |
| Urovant Sciences INC | $84.68 | 2022 | |
| Bluewind Medical | $30.36 | 2025 | Revi |
| Laborie Medical Technologies Corp. | $23.00 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $17.76 | 2023 | Endosee |
| Sumitomo Pharma America, INC. | $17.39 | 2024 | Gemtesa |
| Hollister Incorporated | $12.99 | 2023 | Infyna Chic, Onli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Hare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.